Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use.Initial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-other
GAMUNEX-C FlexBag is an immune globulin injection (human) 10% liquid that is indicated for the treatment of: GAMUNEX-C FlexBag is indicated for treatment of primary humoral immunodeficiency in patients 2 years of age and older. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. GAMUNEX-C FlexBag is indicated for the treatment of adults and children with Idiopathic Thrombocytopenic Purpura to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery. GAMUNEX-C FlexBag is indicated for the treatment of CIDP in adults to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse.
- generic_name
- immune globulin (human)
- product_names
- Immune Globulin (Human)
- ndc
- 13533-805, 13533-805-00, 13533-805-01, 13533-805-10, 13533-805-11, 13533-805-30, 13533-805-31, 13533-805-44, 13533-805-45
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en